Yeditepe University hospital
Istanbul, İçerenköy, Turkey (Türkiye)
NCT Number: NCT03741465
A prosperous neuraxial anesthesia positioning ensures a raised chance of successful needle placement. The primary aim is to compare "The Anatolian sitting position-ASP" with "The Sitting Fetal Position-SFP" sonographically. Secondary aim is to compare their comfort.
Looking for future studies?
Notify Me18 year–45 year
All sexes
Interventional
Not applicable
Istanbul, İçerenköy, Turkey (Türkiye)
Fifty participants were included to this prospective, randomized, consecutive controlled clinical study. Six parameters were evaluated in each position; subcutaneous tissue (ST), skin to spinous process (S-SP), transverse diameters of bilateral paraspinal muscles (left paraspinal muscle [LPM] and right paraspinal muscle [RPM]), interspinous gap opening (ISGO), mean of bilateral paraspinal muscles (MPM). The change of every measurement recorded via ultrasonography (USG) according to the positioning techniques (the Anatolian Sitting Position [ASP] could also be named as "sitting fetal cross-legged position" and the Sitting Fetal Position [SFP] which is a traditional sitting position) were also calculated. The calculations are explained briefly in primary outcomes (including the change of ASP-SFP in ST, S-SP, LPM, RPM, MPM, ISGO). Stretcher comfort (SC), position comfort (PC), lumbar comfort (LC), and abdominal comfort (AC) were evaluated by the participants with the 5-point Numerical Rating Scale (NRS).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The USG, and the 5-point NRS evaluation in the SFP
The USG, and the 5-point NRS evaluation in the ASP
Time frame: For the ASP technique, ISGO is measured in the first 10 minutes(mins.) time, for each participant, through study completion.
the wideness measurement of the ISGO in millimeters via ultrasonography (USG) in the ASP
Time frame: For the ASP technique, LPM is measured in between 10mins. and 20mins. time, for each participant, through study completion.
the diameter measurement of the LPM in millimeters via ultrasonography in the ASP
Time frame: For the ASP technique, RPM is measured in between 20mins. and 30mins. time, for each participant, through study completion.
the diameter measurement of the RPM in millimeters via ultrasonography in the ASP
Time frame: For the ASP technique, MPM measurement is planned to be done in between 30mins. and 40mins. time, for each participant, through study completion.
Measured by ( [LPM+RPM]/2) in millimeters in the ASP
Time frame: For the ASP technique, ST measurement is planned to be done in between 40mins. and 50mins. time, for each participant, through study completion.
the thickness measurement of the subcutaneous tissue in millimeters via ultrasonography in the ASP
Time frame: For the ASP technique, S-SP measurement is planned to be done in between 50mins. and 1 hour(hr.) time, for each participant, through study completion.
the depth measurement of the skin to spinous process in millimeters via ultrasonography in the ASP
Time frame: For the SFP technique, ISGO measurement is planned to be done, right after NRS evaluation of the ASP, in between 1hr.10mins. and 1hr.20mins. time, for each participant, through study completion.
the wideness measurement of the ISGO in millimeters via ultrasonography in the SFP
Time frame: For the SFP technique, LPM measurement is planned to be done in between 1hr.20mins. and 1hr.30mins. time, for each participant, through study completion.
the diameter measurement of the LPM in millimeters via ultrasonography in the SFP
Time frame: For the SFP technique, RPM measurement is planned to be done in between 1hr.30mins. and 1hr.40mins. time, for each participant, through study completion.
the diameter measurement of the RPM in millimeters via ultrasonography in the SFP
Time frame: For the SFP technique, MPM measurement is planned to be done in between 1hr.40mins. and 1hr.50mins. time, for each participant, through study completion.
Measured by ( [LPM+RPM]/2) in millimeters in the SFP
Time frame: For the SFP technique, ST measurement is planned to be done in between 1hr.50mins. and 2hrs. time, for each participant, through study completion.
the thickness measurement of the subcutaneous tissue in millimeters via ultrasonography in the SFP
Time frame: For the SFP technique, S-SP measurement is planned to be done in between 2hrs. and 2hr.10mins. time, for each participant, through study completion.
the depth measurement of the skin to spinous process in millimeters via ultrasonography in the SFP
Time frame: ISGO in the ASP is measured in the first 10mins., and ISGO in the SFP is measured in between 1hr.10 mins. and 1hr.20mins. time, through study completion.
Measured by calculation; ([ISGO in the ASP in millimeters]-[ISGO in the SFP in millimeters])
Time frame: LPM in the ASP is measured in between 10mins. and 20mins. time, and LPM in the SFP is measured in between 1hr.20mins and 1hr.30mins. time, through study completion.
Measured by calculation; ([LPM in ASP in millimeters]-[LPM in SFP in millimeters])
Time frame: RPM in the ASP is measured in between 20mins. and 30mins. time, and RPM in the SFP is measured in between 1hr.30mins. and 1hr.40mins. time, through study completion.
Measured by calculation ([RPM in ASP in millimeters]-[RPM in SFP in millimeters])
Time frame: MPM in the ASP is measured in between 30mins. and 40mins. time, and MPM in the SFP is measured in between 1hr.40mins and 1hr.50mins. time, through study completion.
Measured by calculation ([MPM in ASP in millimeters]-[MPM in SFP in millimeters])
Time frame: ST in the ASP is measured in between 40mins. and 50mins. time, and in the SFP is measured in between 1hr.50mins and 2hrs. time, through study completion.
Measured by calculation ([ST in ASP in millimeters]-[ST in SFP in millimeters])
Time frame: S-SP in the ASP is measured in between 50mins. and 1hr. time, and S-SP in the SFP is measured in between 2 hrs. and 2hrs.10mins. time, through study completion.
Measured by calculation ([S-SP in ASP in millimeters]-[S-SP in SFP in millimeters])
Time frame: NRS measurement is planned to be done right after the ASP position in between 1hr. and 1hr.10mins. time, for each participant, through study completion.
Comfort evaluation of the ASP technique is planned to be done by the participant right after USG. The 5-point NRS includes 5 scale. The minimum scale is"1" means poor, "2" means fair, "3" means good, "4" means very good, and the maximum scale is "5" means excellent.
Time frame: NRS measurement is planned to be done right after the SFP position in between 2hrs.10mins. and 2hrs.20mins. time, for each participant, through study completion.
Comfort evaluation of the SFP technique is planned to be done by the participant right after USG. The 5-point NRS includes 5 scale. The minimum scale is"1" means poor, "2" means fair, "3" means good, "4" means very good, and the maximum scale is "5" means excellent.
Yeditepe University
Other
"The Anatolian Sitting Neuraxial Position Technique"; is it Beneficial? A Prospective Clinical Comparison Trial Via Ultrasonography
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07326436
Anesthesia, Conduction, Brachial Plexus Blockade
Izmir, İzmir, Turkey (Türkiye)
View Trial DetailsNCT04928794
Anesthesia, Conduction
Albuquerque, New Mexico, United States
View Trial DetailsNCT06601530
Anesthesia, Conduction, Coronary Artery Bypass
Istanbul, Fatih, Turkey (Türkiye)
View Trial DetailsNCT02457442
Anesthesia, Conduction, Drug Interactions
Bern, Switzerland
View Trial Details